Why the study?
Does high-level expression of viral interleukin-10 in cardiac allografts prolong graft survival in a murine model?
Does high-level expression of viral interleukin-10 in cardiac allografts prolong graft survival in a murine model?
Answers are grounded in this paper and cite their sources.
High-level expression of viral IL-10 in cardiac allografts exacerbates rather than prevents immunological rejection in a murine transplantation model.
BACKGROUND: Viral interleukin (vIL)-10, encoded in the Epstein-Barr virus genome, shares many of the anti-inflammatory properties of cellular IL-10 but is supposed to lack IL-10's immunostimulatory properties. Thus, vIL-10 is expected to offer superior immunosuppression. METHODS: We established transgenic mice (vIL-10 Tg) that express vIL-10 systemically and transplanted their hearts as vascularized allografts into unmodified major histocompatibility complex (MHC) full-mismatch or MHC class II-disparate mice. RESULTS: The vIL-10 Tg mice revealed high-level expression of vIL-10 in major organs including the heart. However, the heart grafts from the vIL-10 Tg mice failed to exhibit prolonged survival in combination with either the MHC full-mismatch or the class II-disparate mice. In the MHC class II-disparate mice, the vIL-10 Tg heart grafts showed severe CD8 T-cell infiltration and increased interferon (IFN)-gamma mRNA expression compared with non-Tg grafts. CONCLUSION: High level expression of vIL-10 in grafts can exacerbate immunological rejection in an allogenic transplantation model.
No takes yet. Share an insight, caveat, or question.
Adachi et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: